Thursday, June 25, 2020

A pricing war? Cipla pips Hetero, fixes remdesivir under Rs 5,000

A senior government official said it is in wait-and-watch mode and has not decided to take any suo motu action on the pricing of the drug

from Today's Paper https://ift.tt/2NrKWu9
via

No comments:

Post a Comment

If you have any doubts please let me know!

India's low score on GVC a starting point for recovery from pandemic: AIIB

India rated 7.4 percentage points below the average global value chain participation rate for emerging economies from Today's Paper ht...